About the Gabapentin Lawsuits for Dementia in 2026
Gabapentin, which is also sold under the brand name Neurontin, is an anti-seizure medication approved by the U.S. Food & Drug Administration (FDA) to treat epileptic seizures and shingles-related nerve pain.
However, the drug has been widely prescribed for a range of unapproved conditions, and studies have linked the medication to an increased risk of dementia and cognitive impairment.
Neurontin and Gabapentin lawsuits allege that Pfizer:
- Marketed gabapentin for off-label uses, including chronic back pain, bipolar disorder, and migraines
- Failed to adequately warn patients about the risk of cognitive issues linked to gabapentin use
- Knew or should have known about these risks, as multiple studies have linked gabapentin to cognitive decline
Patients ages 18-64 who have received 6+ gabapentin prescriptions for back pain are more than twice as likely to develop dementia or mild cognitive impairment, according to Regional Anesthesia & Pain Medicine.
If you or a loved one was prescribed gabapentin and has since been diagnosed with dementia, you may be able to file a gabapentin lawsuit and pursue compensation for medical expenses, pain and suffering, lost wages, and more.
At Sokolove Law, we have over 45 years of experience standing up to negligent pharmaceutical companies and securing justice for patients. Let our gabapentin lawyers fight for you.
Get the Help You Deserve
We’ve helped thousands of families hold powerful companies accountable. Find out if you may be able to file a gabapentin lawsuit now.
Gabapentin and Dementia Risks
Frequent gabapentin users are 29% more likely to develop dementia and 85% more likely to develop mild cognitive impairment within 10 years, according to a 2025 Case Western Reserve University study.
“This study reinforces what many of us in spine care have warned for years: Gabapentin doesn’t meaningfully help most patients with back pain, but it can hurt them – cognitively, functionally, and long-term.”
– Dr. Dawood Sayed, American Society of Pain and Neuroscience
Other studies have revealed similarly troubling results. Gabapentin use was found to increase the risk of dementia by 45%, according to Frontiers in Pharmacology. Cognitively normal adults also experienced a measurable cognitive decline just 2 years after starting gabapentin, according to the National Alzheimer's Coordinating Center database.
Despite these findings, Pfizer hasn’t updated the warning label on gabapentin to include the risk of dementia or cognitive impairment — and those affected may be able to take legal action against the drug’s manufacturer.
Who Can File a Lawsuit for Gabapentin Memory Loss?
To file a lawsuit for gabapentin memory loss, your attorney must be able to show that you or a loved one used this medication and experienced cognitive decline or memory loss as a result.
You may be eligible for a gabapentin lawsuit if you or a loved one:
- Used gabapentin 6 or more times between 2000 and 2024
- Was prescribed gabapentin for something other than nerve pain or seizures
- Received an early-onset dementia diagnosis before age 65
There’s only a limited amount of time to file lawsuits against gabapentin due to laws called statutes of limitations. Once the deadline in your case passes, you may lose your chance to seek justice.
Call (800) 995-1212 now to find out if you may qualify for a gabapentin lawsuit settlement. It costs nothing to speak with us.
How to Join the Gabapentin Lawsuit
At Sokolove Law, we understand the challenges you’re experiencing — and we’re here to make sure you don’t have to face them alone. We'll handle every step of the gabapentin lawsuit process and fight for the justice you deserve.
Our gabapentin lawsuit attorneys can:
- Determine your eligibility to file a claim during a free case review
- Gather evidence like your medical reports and expert testimony to build a strong case on your behalf
- File your Neurontin Pfizer lawsuit before any legal deadlines
- Negotiate a gabapentin settlement with the defendant(s), so you can receive compensation as quickly as possible
- Present your case in court and pursue compensation from a trial verdict if a settlement is unable to be reached
A dementia diagnosis can change everything for you and the people you love. If gabapentin played a role in what your family is going through, you deserve answers, accountability, and compensation.
Pfizer has made billions of dollars selling gabapentin for conditions it was never approved to treat. Taking legal action can allow you to hold the company accountable and seek the financial support your family needs going forward.
"Millions of Americans have been prescribed gabapentin, often for years, trusting that it was safe. If ongoing research confirms that gabapentin can contribute to cognitive decline, patients and their families deserve clear answers about what was known, when it was known, and who should be held accountable."
– Ricky LeBlanc, Managing Attorney of Sokolove Law
Gabapentin Settlements & Verdicts
Pfizer has a long history of being held accountable for their dangerous medications and marketing practices — and gabapentin is no exception. The company has been ordered to pay nearly $1 Billion in fines and settlements linked to gabapentin.
Gabapentin settlements and verdicts include:
- $430 Million for illegally promoting off-label uses of gabapentin
- $190 Million to resolve a consumer fraud Neurontin class action lawsuit
- $325 Million for defrauding insurers by marketing gabapentin for unapproved uses
While there’s never a guarantee of compensation in any case, our gabapentin lawsuit lawyers will fight hard to get you everything you’re entitled to.
Compensation from a gabapentin lawsuit may help cover the cost of memory care and assisted living facilities, in-home care, medical expenses like specialist visits or prescription costs, and more.
Gabapentin Lawsuit News & Updates 2026
Gabapentin was first used to treat seizures in 1993. Now, victims are filing gabapentin lawsuits alleging that the drug caused cognitive issues and that they weren't warned of the risk.
Families are seeking compensation for medical expenses, lost income, pain and suffering, and more. Several high-profile cases involving gabapentin and the brand-name counterpart Neurontin have already resulted in substantial settlements and verdicts.
Court Upholds $142 Million Gabapentin Lawsuit Verdict
A federal appeals court in Boston upheld a $142 Million gabapentin verdict against Pfizer related to the off-label marketing of their epilepsy drug.
The court found that Kaiser Foundation Health Plan was harmed after paying for prescriptions allegedly driven by Pfizer's misleading promotion of the drug for unapproved uses.
According to the lawsuit, Pfizer marketed gabapentin for conditions including bipolar disorder, migraines, and neuropathic pain before the FDA had approved the drug for those uses.
$325 Million Gabapentin Settlement
Pfizer agreed to pay $325 Million to settle allegations that they improperly marketed the epilepsy drug gabapentin for unapproved uses and caused insurers and health care benefit providers to pay for prescriptions that were not medically effective.
The gabapentin settlement resolves a long-running lawsuit alleging that Pfizer and their Warner-Lambert subsidiary promoted gabapentin for conditions not approved by the FDA in an effort to increase sales.
$190 Million Neurontin Class Action Lawsuit Settlement
Pfizer agreed to a $190 Million Neurontin class action lawsuit settlement to resolve claims that they unlawfully delayed generic competition for Neurontin.
The settlement was limited to pharmaceutical wholesalers, distributors, and retail pharmacy chains that bought Neurontin directly from Pfizer
The Neurontin lawsuit claimed that Pfizer used a variety of tactics to protect their monopoly, including filing sham patent lawsuits, making misrepresentations in legal proceedings, and improperly obtaining patents that delayed lower-cost generic versions from entering the market.
$430 Million Neurontin Settlement
Pfizer's subsidiary Parke-Davis agreed to pay $430 Million and plead guilty to criminal charges stemming from allegations that it illegally promoted Neurontin for uses not approved by the FDA.
The lawsuit was originally filed by a former Parke-Davis employee, who alleged the company engaged in a widespread campaign to market the anti-seizure drug for unapproved conditions.
Federal prosecutors claimed these practices violated health care regulations and led to the submission of false claims to government health programs. The settlement resolved both civil and criminal allegations and became one of the first major whistleblower cases involving off-label pharmaceutical marketing.
Let Our Gabapentin Lawyers Fight for You
At Sokolove Law, our gabapentin lawyers have the resources and experience needed to take on major pharmaceutical companies like Pfizer and pursue justice for those harmed by prescription medications.
Find out how Sokolove Law stands out from the rest:
- Over 45 years of litigation experience
- No upfront costs or hourly fees
- Able to help families in all 50 states
- $1.6 Billion+ secured for victims of dangerous drugs and medical devices
Don't wait: Legal deadlines may limit your ability to file a gabapentin lawsuit. The sooner you reach out, the sooner we can start fighting for you.
Call (800) 995-1212 now or fill out our contact form to get started with a free case review. Our team is standing by to answer any questions you may have.
Gabapentin & Neurontin Lawsuit FAQs
Is there a lawsuit about gabapentin?
Yes. Lawsuits have been filed against Pfizer, the manufacturer of gabapentin (Neurontin®), by patients and families who allege the drug is linked to dementia and other forms of cognitive impairment. Many of these cases involve individuals who were prescribed gabapentin for off-label uses, like chronic back pain.
Gabapentin lawsuits claim that Pfizer knew or should have known about the serious cognitive risks linked to gabapentin use, but they failed to adequately warn patients about this risk.
Contact Sokolove Law now to see if you may be eligible for compensation from a gabapentin lawsuit.
Who makes gabapentin?
Gabapentin was originally developed by Parke-Davis, a subsidiary of Warner-Lambert. It is currently manufactured and marketed by Pfizer, one of the largest pharmaceutical companies in the world.
In 2000, Pfizer acquired Warner-Lambert and has since been the subject of nearly $1 Billion in settlements and penalties tied to gabapentin.
Does gabapentin cause memory loss?
Research suggests that long-term gabapentin use may be associated with memory loss and other forms of cognitive decline, including early-onset dementia.
Patients who have taken gabapentin should speak with their doctor right away if they begin experiencing memory loss, forgetfulness, confusion, or other similar symptoms.
Is there a gabapentin class action lawsuit?
Currently, there is no open class action lawsuit for dementia caused by gabapentin. Instead, these lawsuits are being filed individually by families across the country.
This approach allows each case to be evaluated based on an individual’s unique circumstances, like the extent of their cognitive decline, their medical history, and how gabapentin has impacted their quality of life.
What is the gabapentin lawsuit payout per person?
The gabapentin lawsuit payout per person will vary depending on the facts of each case. Potential payouts could range from tens of thousands to over $1 Million in more severe cases.
Compensation will likely depend on factors like the severity of the neurological damage, how it has impacted the patient's life, and whether the case is resolved through a gabapentin settlement or verdict.
How do I find the best lawyers for the gabapentin memory loss lawsuit near me?
The best lawyers for a gabapentin memory loss lawsuit may not work at a local firm. Taking on a major pharmaceutical company like Pfizer often requires the extensive resources of a national product liability law firm.
For over 45 years, Sokolove Law has successfully helped thousands of families secure justice, recovering more than $1.6 Billion for those harmed by dangerous drugs and medical devices.
Call (800) 995-1212 now to see if our lawyers for the gabapentin lawsuit may be able to fight for you.
How much do gabapentin lawsuit lawyers cost?
At Sokolove Law, there are no upfront costs or hourly fees to work with our gabapentin lawsuit lawyers.
We operate on a contingency-fee basis, which means you pay nothing unless we secure compensation for your family.
